Device for the treatment of malaria A method and device for the treatment of malaria which comprises applying microwave energy to a patient under non-thermal conditions. The non-thermal conditions are achieved by applying the microwave energy under conditions that the normal heating effects of microwaves are not significant. For example, microwave energy may be switched on in pulses lasting less than 6 seconds.

The present disclosure provides a microwave transmission method and a single-input multiple-output waveguide microwave system based on frequency control, an electronic device. The method includes: adjusting frequency of an input microwave, each of different input microwaves with different frequencies being input microwave of the single-input multi-output waveguide microwave system; assigning the input microwave to a target output port among multiple output ports of the single-input multiple-output waveguide microwave system, according to the frequency of the input microwave; and performing microwave output through the target output port.

Methods of treating a subject are provided, involving providing a first region of biological material coupled to the subject; initiating a change in a cellular environment of the cells in the first region; and due to a change in biological or chemical activity of the cells in the first region, inducing a biological change in a second region inside the subject, along with various biophoton collectors and biophoton bypasses useful for implementing a variety of the method embodiments.

An antenna assembly for microwave ablation can include a radiator for emitting a microwave for ablation; a coaxial cable for transmitting the microwave for ablation generated by a microwave generator to the radiator; an annular composite structure is provided around the coaxial cable for inhibiting an electromagnetic wave from propagating backwards along the coaxial cable. In some embodiment, the annular composite structure comprises an annular nonmetallic layer and an annular metallic layer located outside the annular nonmetallic layer. In some embodiments, the annular metallic layer is electrically insulated from the coaxial cable. In some embodiments, the antenna assembly can be used with a microwave ablation needle. The annular composite structure can inhibit the backward propagation of the microwave along the coaxial cable exterior wall. In some embodiments, circulation water enters the radiation zone, to avoid high temperatures of the head the ablation needle.

The invention generally relates to methods of stimulating tissue based upon filtering properties of the tissue. In certain aspects, the invention provides methods for stimulating tissue that involve analyzing at least one filtering property of a region of at least one tissue, and providing a dose of energy to the at least one region of tissue based upon results of the analyzing step.

Methods and devices for treating nasal airways are provided. Such devices and methods may improve airflow through an internal and/or external nasal valve, and comprise the use of mechanical re-shaping, energy application and other treatments to modify the shape, structure, and/or air flow characteristics of an internal nasal valve, an external nasal valve or other nasal airways.

A process for heat treating biological tissue includes providing a plurality of energy emitters formed into an array. Treatment energy in the form of microwave energy is generated from the plurality of emitters and applied to target tissue. The treatment energy has energy and application parameters selected so as to raise the target tissue temperature sufficiently to create a therapeutic effect while maintaining an average temperature of the target tissue over several minutes at or below a predetermined temperature so as not to destroy or permanently damage the target tissue.

A process for heat treating biological tissue includes providing a plurality of energy emitters formed into an array. Treatment energy in the form of light beams is generated from the plurality of emitters and applied to target tissue. The treatment energy has energy and application parameters selected so as to raise the target tissue temperature sufficiently to create a therapeutic effect while maintaining an average temperature of the target tissue over several minutes at or below a predetermined temperature so as not to destroy or permanently damage the target tissue.

A sterilization system having a controllable non-ionizing microwave radiation source for providing microwave energy for combining with a gas to produce atmospheric low temperature plasma for sterilizing biological tissue surfaces or the like. A plasma generating region may be contained in a hand held plasma applicator. The system may include an impedance adjustor e.g. integrated in the plasma applicator arranged to set a plasma strike condition and plasma sustain condition. The gas and microwave energy may be transported to a plasma generating region along an integrated cable assembly. The Integrated cable assembly may provide a two way gas flow arrangement to permit residual gas to be removed from the surface. Invasive surface plasma treatment is therefore possible. The plasma applicator may have multiple plasma emitters to produce a line or blanket of plasma.

Disclosed are a sensitizing composition for thermal cancer therapy using electromagnetic waves and a method of treating cancer using the composition. The sensitizing composition includes a metal ion, a metal ion-bound material, “metal ion-noncovalently bound apotransferrin” (transferrin), or a metal ion-noncovalently bound apotransferrin derivative. The sensitizing composition enables selective delivery of the metal ion to tumorous tissue when administered in vivo, and thus the generation of heat in tumorous tissue in which the metal ion accumulates is increased upon thermal cancer therapy using electromagnetic waves, thereby maximizing efficacy of thermal cancer therapy using electromagnetic waves in treating cancer. Thermal therapy using the sensitizing composition effectively treats cancer without pain or side effects and is thus expected to be widely useful in anticancer treatment as monotherapy, and/or in combination with chemotherapy, radiation therapy, or a combination thereof, ultimately increases the potential to cure cancer.